期刊文献+
共找到1,929篇文章
< 1 2 97 >
每页显示 20 50 100
Therapeutic Effect of Nifedipine Combined with Enalapril on Elderly Patients with Coronary Heart Disease Complicated with Hypertension
1
作者 Xiaoye Wang 《Journal of Clinical and Nursing Research》 2018年第6期1-4,共4页
The objective of this study was to analyze the efficacy of combined drug therapy for elderly patients with coronary heart disease and hypertension.66 elderly patients with coronary heart disease and hypertension were ... The objective of this study was to analyze the efficacy of combined drug therapy for elderly patients with coronary heart disease and hypertension.66 elderly patients with coronary heart disease and hypertension were enrolled from December 2016 to November 2017.They were randomly divided into two groups,33 patients in each group.Patients in the experimental group received nifedipine.In combination with enalapril,patients enrolled in the control group received nifedipine monotherapy.Compared with the control group,the total effective rate,serum nitric oxide(NO)after treatment,C-reactive protein(CRP)after treatment,homocysteine(HCY)after treatment,and blood pressure after treatment were significantly improved(P<0.05).There were no significant differences in serum NO,pre-treatment CRP,pre-treatment HCY,pre-treatment blood pressure,and adverse reactions during treatment between the two groups(P>0.05).The elderly patients with coronary heart disease and hypertension are treated with nifedipine and enalapril. 展开更多
关键词 old age coronary heart disease hypertension NIFEDIPINE ENALAPRIL
下载PDF
Effects of telmisartan combined with nifedipine controlled release tablet on inflammatory factors, vascular endothelial function and left ventricular function in patients with coronary heart disease with mild to moderate hypertension
2
作者 Feng Guo Bao-Wei Zhang Zheng-Yan Zhu 《Journal of Hainan Medical University》 2017年第20期14-18,共5页
Objective: To investigate the effect of telmisartan combined with Nifedipine Controlled Release Tablet on inflammatory factors, vascular endothelial function and left ventricular function in patients with coronary hea... Objective: To investigate the effect of telmisartan combined with Nifedipine Controlled Release Tablet on inflammatory factors, vascular endothelial function and left ventricular function in patients with coronary heart disease with mild to moderate hypertension. Methods:A total of 92 cases of patients with coronary heart disease with mild to moderate hypertension were selected as the object of observation, according to the random data table, they were divided into the control group (n=46) and observation group (n=46), and patients in the control group were treated with Nifedipine Controlled Release Table therapy, on this basis, the observation group patients were given telmisartan treatment, two groups were treated for 6 months. The levels of the blood pressure, inflammatory factors, vascular endothelial function and left ventricular function compared between the two groups before and after treatment. Results: There were no significant differences in the levels of SBP, DBP, hs-CRP, TNF-α, NO, ET-1, LVEF, LVEDD and LVESD in the two groups before treatment. After treatment, two groups of SBP, DBP, hs-CRP, TNF-α, ET-1, LVEDD and LVESD levels were significantly lower than those in the same group before treatment, and after treatment, the levels of SBP, DBP, hs-CRP, TNF-α, ET-1 and LVESD in the observation group were significantly lower than those in the control group, while there were no significant difference in the level of LVEDD between the two groups after treatment;Compared with level in the group before treatment, the levels of NO and LVEF in the two groups were significantly increased, and the observation group [(82.13±19.01) μmol/L, (52.83±7.45)%] was significantly higher than the control group ((67.37±13.08) μmol/L, (49.47±6.96)%)Conclusion: Telmisartan combined with Nifedipine Controlled Release Table in treating coronary heart disease with mild to moderate hypertension, can effectively control blood pressure, reduce the inflammatory stress, improve vascular endothelial function and left ventricular function of patients, has an important clinical value. 展开更多
关键词 coronary heart disease with mild to moderate hypertension TELMISARTAN NIFEDIPINE Controlled Release Table Inflammatory factors Vascular ENDOTHELIAL FUNCTION Left VENTRICULAR FUNCTION
下载PDF
Arterial hypertension and electrocardiographic diagnosis of left ventricular hypertension in the group of geriatric patients with coronary heart disease living in the far north 被引量:2
3
作者 Natalya Arkhipova Elena Popova Aleksandr Ariev 《Health》 2013年第6期122-127,共6页
As a result of research, high prevalence of arterial hypertension has been identified in the group of patients with coronary heart disease aged 60 and older. Most often, occurring form of arterial hypertension among g... As a result of research, high prevalence of arterial hypertension has been identified in the group of patients with coronary heart disease aged 60 and older. Most often, occurring form of arterial hypertension among geriatric patients is isolated systolic arterial hypertension (ISAH). The comparison of two ethnic groups of the population has showed higher levels of systolic and diastolic blood pressure (SBP and DBP) in the group of patients of non-indigenous nationality, rather than Yakut patients. Correlation was recorded in the group of non-indigenous patients as they age. Significant increase in the level of SBP was identified in the group of senile and long-livers than in the elderly. Detection of ECG signs of LVH showed the lowest specificity of Cornell voltage criterion comparing to Sokolow-Lyon criterion with its more often occurrence. ECG-signs of left ventricle hypertrophy are significantly more often established by Sokolow-Lyon criterion for men, Cornell voltage—for women. Correlation has been found between the presence of LVH and combination of Cornell voltage criterion with both Gubner-Ungerleider and Sokolow-Lyon criteria. 展开更多
关键词 Arterial hypertension coronary heart disease GERIATRIC Age NON-INDIGENOUS and Yakut Patients Electrocardiographic Criteria of Left VENTRICLE HYPERTROPHY
下载PDF
Combined effects of hypertension and angiotensin Ⅱ on the risk of coronary heart disease:a population-based prospective cohort study among Inner Mongolians in China
4
作者 Yiting Zhou 《中国循环杂志》 CSCD 北大核心 2018年第S01期111-111,共1页
Objective To investigate the combined effects of hypertension and angiotensinⅡon the risk of coronary heart disease(CHD)on the basis of a 10-year prospective study in an Inner Mongolian population of China.Methods Ba... Objective To investigate the combined effects of hypertension and angiotensinⅡon the risk of coronary heart disease(CHD)on the basis of a 10-year prospective study in an Inner Mongolian population of China.Methods Based on a cross-sectional survey,a prospective cohort study was conducted from June 2003 to July 2012 among 2,530 Mongolian people. 展开更多
关键词 effects hypertension angiotensinⅡ coronary heart disease(CHD)
下载PDF
Clinical characteristics of Danshen Ligustrazine injection in the treatment of coronary heart disease with hypertension-A real world study
5
作者 SUN Lin-xi Gao Yang +3 位作者 XIE Yan-ming Zhang Li-dan XU Hong-yan ZHUANG Yan 《Journal of Hainan Medical University》 2022年第17期39-46,共8页
Objective:To explore the characteristics and rules of Danshen Ligustrazine Injection in the treatment of coronary heart disease with hypertension.Methods:From the information systems of 12 tertiary tier-one hospitals ... Objective:To explore the characteristics and rules of Danshen Ligustrazine Injection in the treatment of coronary heart disease with hypertension.Methods:From the information systems of 12 tertiary tier-one hospitals across the country,we extracted the medical data of the application of Danshen Ligustrazine Injection in the treatment of patients with coronary heart disease and hypertension.After normalization,the model was established by Apriori algorithm,and the association rules were analyzed by Clementine 12.0 software.Results:Most of the 1928 patients were between 75 and 90 years old(54.26%).There were more males than females,most with type 2 diabetes,cerebral infarction,etc.Each dose was more than 10 mL(52.78%).Aspirin enteric-coated tablets(67.63%),L-carnitine injection(58.77%),and atorvastatin calcium capsules(50.93%)were often used in combination with safflower yellow pigment(22.20%),Shexiang Baoxin Pill(16.55%),Suxiao Jiuxin Pill(15.09%);the most commonly used combination of western medicine was anticoagulant thrombolytic and antiplatelet drugs(85.84%),and the type of Chinese medicine was Huoxuehuayu(72.98%);The most common combination of two western medicines was L-carnitine injection+aspirin enteric-coated tablets,with a support of 41.9%;The most common combination of two Chinese and western medicines is western medicine·anti-anginal medicine+western medicine·anticoagulant thrombolytic and antiplatelet drugs with a support of 67.6%.Conclusion:Danshen Ligustrazine injection is mainly used in elderly patients with coronary heart disease and hypertension,with many comorbidities.The dosage standard needs to be optimized.The combination of drugs and guidelines should coordinate with each other,which provide clues for clinical diagnosis and treatment and optimization of medication. 展开更多
关键词 Real world Danshen Ligustrazine Injection coronary heart disease hypertension Combination medication
下载PDF
Correlation between serum Hcy content and coronary atherosclerosis severity in patients with H-type hypertension and coronary heart disease
6
作者 Xiao-Mei Li Fu-Yuan Liu 《Journal of Hainan Medical University》 2017年第3期36-39,共4页
Objective:To analyze the correlation between serum Hcy content and coronary atherosclerosis severity in patients with H-type hypertension and coronary heart disease. Methods: 48 patients with H-type hypertension and c... Objective:To analyze the correlation between serum Hcy content and coronary atherosclerosis severity in patients with H-type hypertension and coronary heart disease. Methods: 48 patients with H-type hypertension and coronary heart disease were selected as observation group, and 57 patients with normal hypertension and coronary heart disease were selected as control group. Echocardiography was used to determine coronary lesion parameters, enzyme-linked immunosorbent assay (ELISA) was used to determine serum levels of homocysteine (Hcy) and coronary heart disease-related indexes, and the correlation between Hcy levels and coronary heart disease was further analyzed. Results:Serum Hcy level of observation group was higher than that of control group (P<0.05), absolute GLPSS value and E/A value under echocardiography were less than those of control group while E-DT and E/e value were higher than those of control group (P<0.05);serum adiponectin (APN) level was lower than that of control group while P-selectin, asymmetric dimethylarginine (ADMA), oxidized high-density lipoprotein (OX-HDL), MMP-2, MMP-9, lipoprotein-associated phospholipase A2 (Lp-PLA2) and Resistin levels were higher than those of control group (P<0.05);Hcy was negatively correlated with absolute GLPSS value, E/A value and APN level, and was positively correlated with E-DT value, E/e value as well as P-selectin, ADMA, OX-HDL, MMP-2, MMP-9, Lp-PLA2 and Resistin levels (P<0.05). Conclusions:There is direct correlation between serum Hcy levels and the severity of coronary heart disease in patients with H-type hypertension and coronary heart disease, it can be a reliable way to early screen for coronary heart disease and evaluate the illness, and it is also a new target of coronary heart disease intervention. 展开更多
关键词 H-type hypertension coronary heart disease HOMOCYSTEINE
下载PDF
The Correlation between Free Triiodothyronine, Free Thyroxine and Hypertension in Depression Patients with Hypothyroidism and Its Clinical Guiding Value
7
作者 Jingxuan Liu Fang Wang Xinhua Zhou 《Journal of Biosciences and Medicines》 2024年第6期191-201,共11页
Background: Cardiovascular diseases, such as hypertension and coronary heart disease, are often accompanied by thyroid and mental diseases, the harm of which poses great threats to patients’ health. Objective: To exp... Background: Cardiovascular diseases, such as hypertension and coronary heart disease, are often accompanied by thyroid and mental diseases, the harm of which poses great threats to patients’ health. Objective: To explore the correlation between free triiodothyronine (FT3), free thyroxine (FT4) and hypertension in depression patients with hypothyroidism and its clinical guiding value. Methods: A total of 548 patients diagnosed with hypothyroidism in Wuxue First People’s Hospital of Hubei Province from January 2018 to September 2022 were enrolled. According to whether complicated with depression, they were divided into hypothyroidism without depression group (group A) and hypothyroidism with depression group (group B). The gender, age, comorbidities (such as depression, hypertension, diabetes, dyslipidemia, acute myocardial infarction), FT3, FT4, and thyroid stimulating hormone (TSH) levels were recorded. Spearman rank correlation was used to analyze hypertensive patients with hypothyroidism. Multivariate binary Logistic regression was used to analyze the influencing factors of hypertension in patients with hypothyroidism. Results: The TSH level, the number of hypertension, coronary heart disease and hyperlipidemia in group B were statistically significantly higher than those in group A (P 3 level in group B was statistically significantly lower than that in group A (P s = 0.092), coronary heart disease (rs = 0.000), hyperlipidemia (rs = 0.000), diabetes (rs = 0.000), and age (rs = 0.000), and negatively correlated with FT3 (rs = 0.000) (P 3 and FT4 were the influencing factors of hypertension. The risk of hypertension in patients with coronary heart disease and hyperlipidemia significantly increased by 3.425 and 1.761 times (P 3, the risk of hypertension increased (P 4, the risk of hypertension significantly increased (P 3 and FT4 are the influencing factors of hypertension. The lower the FT3 level, the higher the FT4 level, the higher the risk of hypertension. FT3 and FT4 may be potential biomarkers of depression in hypertensive patients. Thyroid function assessment is recommended in patients with hypertension. 展开更多
关键词 HYPOTHYROIDISM DEPRESSION hypertension coronary heart disease Correlation Analysis FT3 FT4
下载PDF
Real-time Three-dimensional Echocardiographic Assessment of Left Ventricular Remodeling Index in Patients with Hypertensive Heart Disease and Coronary Artery Disease 被引量:14
8
作者 陈明 王静 +5 位作者 谢明星 王新房 吕清 王蕾 李燕 付曼丽 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2009年第1期122-126,共5页
Left ventricular remodeling index (LVRI) was assessed in patients with hypertensive heart disease (HHD) and coronary artery disease (CAD) by real-time three-dimensional echocardiography (RT3DE). RT3DE data of ... Left ventricular remodeling index (LVRI) was assessed in patients with hypertensive heart disease (HHD) and coronary artery disease (CAD) by real-time three-dimensional echocardiography (RT3DE). RT3DE data of 18 patients with HHD, 20 patients with CAD and 22 normal controis (NC) were acquired. Left ventricular end-diastolic volume (EDV) and left ventricular end-diastolic epicardial volume (EDVepi) were detected by RT3DE and two-dimensional echocardiography Simpson biplane method (2DE). LVRI (left ventricular mass/EDV) was calculated and compared. The results showed that LVRI measurements detected by RT3DE and 2DE showed significant differences inter-groups (P〈0.01). There was no significant difference in NC group (P〉0.05), but significant difference in HHD and CAD intra-group (P〈0.05). There was good positive correlations between LVRI detected by RT3DE and 2DE in NC and HHD groups (t=0.69, P〈0.01; r=0.68, P〈0.01), but no significant correlation in CAD group (r=0.30, P〉0.05). It was concluded that LVRI derived from RT3DE as a new index for evaluating left ventricular remodeling can provide more superiority to LVRI derived from 2DE. 展开更多
关键词 echocardiography real-time three-dimensional left ventricular remodeling index hypertensive heart disease coronary artery disease
下载PDF
Combined Effect of Smoking and Obesity on Coronary Heart Disease Mortality in Male Veterans:A 30-year Cohort Study 被引量:7
9
作者 SAI Xiao Yong GAO Feng +5 位作者 ZHANG Wen Yu GAO Meng YOU Jing SONG Yu Jian LUO Ting Gang SUN Yuan Yuan 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2021年第3期184-191,共8页
Objective Evidence is lacking regarding the combined effects of smoking and obesity on mortality from coronary heart disease in male veterans.This study aimed to explore the combined effect of smoking and obesity on c... Objective Evidence is lacking regarding the combined effects of smoking and obesity on mortality from coronary heart disease in male veterans.This study aimed to explore the combined effect of smoking and obesity on coronary heart disease mortality in male veterans in China.Methods A cohort of 1,268 male veterans from 22 veteran centers in Xi’an(Shaanxi Province,China)were followed up once every 2 years from February 1,1987 to October 30,2016.The endpoint was death from any cause.The hazard ratio(HR)of each risk factor and the 95%confidence interval(CI)were calculated using a multivariate Cox proportional hazard model.Results The total follow-up was 24394.21 person-years;each subject was followed up for a mean duration of 19.24 years.By the end of the study,of the 1,268 veterans,889 had died,363 were alive,and 16 were lost to follow-up.Cox regression analysis results revealed that current smoking(HR:1.552,95%CI:1.074–2.243),obesity(HR:1.625,95%CI:1.024–2.581),and the combined effect of the two factors(HR:2.828,95%CI:1.520–5.262)were associated with coronary heart disease mortality.Conclusion Our results suggest that obese veterans who smoke might be an important target population for coronary heart disease mortality control. 展开更多
关键词 SMOKING OBESITY coronary heart disease combined effect Cohort study
下载PDF
Study on Features of Insulin Resistance in Patients with Coronary Heart Disease
10
作者 罗义 郭南山 +2 位作者 李广镰 潘宜智 曾冲 《South China Journal of Cardiology》 CAS 2001年第1期1-5,12,共6页
Objective Researching the features of insulin resistance in patients with coronary heart disease (CHD) . Methods The study included 20 healthy subjects (control group), 53 CHD patients without (Group A) and 24 with es... Objective Researching the features of insulin resistance in patients with coronary heart disease (CHD) . Methods The study included 20 healthy subjects (control group), 53 CHD patients without (Group A) and 24 with essential hypertension (Group B) . Oral glucose tolerance test was administered to all subjects. Venous blood samples were taken during fasting and at 30, 60, 120 and 180 min after the glucose load (100g). All samples were assayed for glucose, insulin and C - peptide. Results The glucose, insulin, and C - peptide curves were at a hierarchy of Group B > Group A > the control group. Insulin - sensitivity - index was at an inverse hierarchy (-4. 31±0.55, -4. 05±0.47, - 3. 82±0. 42, respectively) . The ratio of the area under the C - peptide to the insulin was at a hierarchy of control group (3. 84±0. 81)> Group A (2. 84±0. 93)> Group B (2.26±0. 67), P < 0. 01) . As to insulin and C - peptide releasing types, most subjects of the control group had common type, while the predominant response type was pure - high in Group A, delayed - and delayed - high in Group B. Conclusions There are insulin resistance, insulin - C - peptide separation and changes of insulin and C - peptide releasing types in CHD patients. Insulin resistance is more severe when with hypertension. The hyperinsulinemia in CHD might be due to the over - secretion of insulin, also due to slow clearance in the patients accompanied by hypertension. 展开更多
关键词 coronary heart disease hypertension Insulin resistance Hyperinsulinemia
下载PDF
High adiponectin levels fail to protect against the risk of hypertension and,in women,against coronary disease:involvement in autoimmunity? 被引量:3
11
作者 Altan Onat Mesut Aydln +3 位作者 Günay Can Bayram Kroglu Ahmet Karagz Servet Altay 《World Journal of Diabetes》 SCIE CAS 2013年第5期219-226,共8页
AIM:To investigate whether serum adiponectin protects against cardiometabolic risk in a population sample with prevailing metabolic syndrome.METHODS:Middle-aged adults representative of a general population with basel... AIM:To investigate whether serum adiponectin protects against cardiometabolic risk in a population sample with prevailing metabolic syndrome.METHODS:Middle-aged adults representative of a general population with baseline circulating adiponectin measurements(n=1224)were analyzed prospectively at a mean of 3.8 years’follow-up,using continuous values or sex-specific tertiles.Total adiponectin was assayed by an ELISA kit.Type-2 diabetes was identified by criteria of the American Diabetes Association.Hypertension was defined as a blood pressure≥140 mmHg and/or≥90 mmHg and/or use of antihypertensive medication.Outcomes were predicted using Cox proportional hazards regression analysis in models that were controlled for potential confounders.RESULTS:In models of multiple linear regression,sex hormone-binding globulin,fasting insulin(inverse)and,in men,age were significant independent covariates of serum adiponectin which further tended in women to be positively associated with serum creatinine.Cox regression analyses for incident coronary heart disease(CHD),adjusted for sex,age,non-HDL cholesterol,waist circumference and C-reactive protein,revealed significant inverse association with adiponectin tertiles in men but not women(HR=0.66;95%CI:0.32-1.38 for highest tertile).Cox regression for type-2 diabetes in a similar model(wherein glucose replaced non-HDL cholesterol),adiponectin tertiles appeared to protect in each gender.HR for incident hypertension roughly displayed unity in each of the adiponectin tertiles(P-trend=0.67).CONCLUSION:High adiponectin levels failed to protect against the development of hypertension and,in women,against CHD,presumably paralleling impairment in renal function as well.Involvement of adiponectin in autoimmune complex with loss of antioxidative-antiatherogenic properties may be underlying. 展开更多
关键词 ADIPONECTIN ANTIOXIDATIVE function coronary heart disease CREATININE Type-2 diabetes hypertension
下载PDF
The link between dietary nutrients intake and cardiovascular diseases in cold regions
12
作者 Rennan Feng Qianqi Hong +5 位作者 Jingjing Cao Jian Li Lanxin Deng Jing Wang Yang Zhao Cheng Wang 《Frigid Zone Medicine》 2024年第1期1-11,共11页
Background:The cold winter weather in northern China influences the dietary habits of its residents,contributing to a heightened risk of cardiovascular disorders,such as hypertension and coronary heart disease.Key fac... Background:The cold winter weather in northern China influences the dietary habits of its residents,contributing to a heightened risk of cardiovascular disorders,such as hypertension and coronary heart disease.Key factors include low vegetable consumption and high salt and fat intakes.This study aims to investigate the relationships between northern dietary nutrient intake in northern China and cardiovascular disorders during the winter season.Methods:A food frequency questionnaire tailored to the actual eating habits in northern China was designed.Retrospective data from 955 Chinese adults were collected from November to March between 2014 to 2023.Logistic regression was employed to analyze the relationship between dietary nutrients and cardiovascular diseases,with model performance assessed using receiver operating characteristic(ROC)curves.Results:Adjusted for gender,age,and body mass index(BMI),an inverse association was observed between vitamin A(OR=0.706,95%CI:0.550,0.907),nicotinic acid(OR=0.584,95%CI:0.447,0.762),phosphorus(OR=0.777,95%CI:0.608,0.994),selenium(OR=0.719,95%CI:0.560,0.923),zinc(OR=0.683,95%CI:0.531,0.880),methionine(OR=0.730,95%CI:0.569,0.936),arginine(OR=0.753,95%CI:0.588,0.964),lysine(OR=0.706,95%CI:0.550,0.907),aspartic acid(OR=0.730,95%CI:0.569,0.936)and hypertension.Additionally,a negative association was found between niacin(OR=0.752,95%CI:0.597,0.946)and coronary heart disease.Conversely,a positive association was identified between iodine and hypertension(OR=1.305,95%CI:1.020,1.669)and coronary heart disease(OR=1.301,95%CI:1.037,1.634).Conclusion:Our study suggests that maintaining a balanced dietary intake of vitamin A,niacin,phosphorus,selenium,zinc,methionine,arginine,lysine,and aspartic acid can be beneficial in preventing hypertension.Adequate niacin intake is associated with a lower risk of coronary heart disease.However,excessive iodine intake may contribute to hypertension and coronary heart disease. 展开更多
关键词 NUTRIENTS NORTHERN hypertension coronary heart disease COLD
下载PDF
Prevalence and clinical characteristics of atrial fibrillation in hospitalized patients with coronary artery disease and hypertension: a cross-sectional study from 2008 to 2018 被引量:2
13
作者 Qian Xin Sijin Zhang +10 位作者 Chi Wang Siyu Yao Cuijuan Yun Yizhen Sun Ziwei Hou Miao Wang Maoxiang Zhao Lu Tian Yanjie Li Zekun Feng Hao Xue 《Chinese Medical Journal》 SCIE CAS CSCD 2023年第5期588-595,共8页
Background: The clinical characteristics of patients with the comorbidities of hypertension and coronary artery disease (HT-CAD) and atrial fibrillation (AF) are largely unknown. This study aimed to investigate the pr... Background: The clinical characteristics of patients with the comorbidities of hypertension and coronary artery disease (HT-CAD) and atrial fibrillation (AF) are largely unknown. This study aimed to investigate the prevalence of AF in patients with HT-CAD and clinical characteristics of patients with both HT-CAD and AF. Methods: This cross-sectional study was conducted in Chinese People’s Liberation Army General Hospital in Beijing, China, and included 20,747 inpatients with HT-CAD with or without AF from August 2008 to July 2018. We examined the overall prevalence, clinical characteristics, comorbidity profiles, treatment patterns, and blood pressure (BP) control of patients with both HT-CAD and AF. Multivariate logistic regression was used to investigate the associations of cardiovascular risk factors with AF in patients with HT-CAD. Results: The overall prevalence of AF in patients with HT-CAD was 4.87% (1011/20,747), and this increased with age;to be specific, the prevalence in women and men increased from 0.78% (2/255) and 1.02% (26/2561) at the age of <50 years to 8.73% (193/2210) and 10.28 % (298/2900) at the age of ≥70 years, respectively. HT-CAD patients who had AF had a higher prevalence of cardiovascular-related comorbidities than those without AF. Multivariate logistic regression showed that age, gender (male), body mass index, heart failure, and chronic kidney disease were independently associated with the risk of AF in patients with HT-CAD. For those with both HT-CAD and AF, 73.49% (743/1011) had a CHA 2 DS 2 -VASc score of ≥4, and only about half of them had the BP controlled at <140/90 mmHg, which indicated a high risk of thromboembolism and stroke. The use of oral anticoagulation increased during the study period (10.00% [20/200] in 2008 to 2011 vs. 30.06% [159/529] in 2015 to 2018, P < 0.01), but remained at a relatively low level. Conclusions: AF is highly prevalent among patients with HT-CAD. Patients with both HT-CAD and AF have a higher prevalence of cardiovascular-related comorbidities, lower BP control rate, and lower use of oral anticoagulation. 展开更多
关键词 ANTICOAGULATION Atrial fibrillation COMORBIDITIES coronary heart disease hypertension PREVALENCE
原文传递
不同年龄段早发冠心病患者临床特征及危险因素的分析 被引量:1
14
作者 曲政 尤斌 李平 《心肺血管病杂志》 CAS 2024年第5期433-437,共5页
目的:探究不同年龄段早发冠心病患者的临床特征以及危险因素。方法:选择2021年6月至2022年8月,在北京安贞医院门诊诊断为早发冠心病的380例患者作为研究对象,40岁<患者年龄≤59岁为中青年组,中青年组150例,59岁<患者年龄≤65岁为... 目的:探究不同年龄段早发冠心病患者的临床特征以及危险因素。方法:选择2021年6月至2022年8月,在北京安贞医院门诊诊断为早发冠心病的380例患者作为研究对象,40岁<患者年龄≤59岁为中青年组,中青年组150例,59岁<患者年龄≤65岁为老年组,老年组230例。对两组患者的临床资料、实验室检查指标、冠心病的影响因素、冠状动脉病变情况及介入治疗后安全性,进行单因素分析,对单因素分析差异有统计学意义的因素带入多元线性回归,分析相关影响因素。结果:两组患者一般资料对比,仅性别差异有统计学意义(P<0.05)。与中青年组相比,老年组患者的Cr、血浆凝血酶原时间(prothrombin time,PT)、FIB水平明显高,但老年组的谷氨酸转肽酶、TG、Hcy以及PLT都明显低于中青年组,差异有统计学意义(P<0.05)。多因素Logistic回归分析结果显示,Hcy、FIB进入回归模型;老年组3支病变者发生率均比较高(P<0.05),冠状动脉造影术后总的不良事件发生率更多(P<0.05)。结论:不同年龄段早发冠心病患者在临床实验室指标及预后方面存在差异。 展开更多
关键词 早发冠心病 高血压 高血脂 临床效果
下载PDF
心肺联合康复对冠心病介入治疗后患者血脂、心肺功能的影响 被引量:1
15
作者 马卉 牛静 +3 位作者 侯萍 辛薇 王苏 马利祥 《武警医学》 CAS 2024年第7期558-561,566,共5页
目的探讨心肺联合康复对冠心病介入治疗后患者血脂、心肺功能的影响。方法选择2022-11至2023-11秦皇岛市第一医院收治的接受介入治疗后的冠心病患者180例为研究对象,随机分为对照组(n=89)和试验组(n=91),对照组进行常规药物治疗,试验组... 目的探讨心肺联合康复对冠心病介入治疗后患者血脂、心肺功能的影响。方法选择2022-11至2023-11秦皇岛市第一医院收治的接受介入治疗后的冠心病患者180例为研究对象,随机分为对照组(n=89)和试验组(n=91),对照组进行常规药物治疗,试验组进行心肺联合康复治疗,干预时间均为3个月。对两组患者干预前后的血脂水平、心肺功能、运动功能、生活质量和自我管理能力进行比较。结果与干预前对比,两组干预后,三酰甘油(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、用力呼气量与用力肺活量比值(FEV/FVC%)、1 s用力呼气量(FEV_(1))、左心室射血分数(LVEF)、生理功能、躯体疼痛等均有明显改善,差异有统计学意义(P<0.05),试验组比对照组各项指标(LDL-C、FEV/FVC%、PEAKVO2等)改善更明显,差异有统计学意义(P<0.05)。结论心肺联合康复可降低冠脉介入术后患者的血脂水平,增强心肺功能及运动功能,提高生活质量。 展开更多
关键词 心肺联合康复 心脏康复 冠心病 生活质量 血脂
下载PDF
血清CTRP3、Lp-PLA2、Gal-3水平在原发性高血压继发冠心病患者中的变化及临床意义 被引量:1
16
作者 宋红星 《检验医学与临床》 CAS 2024年第7期972-975,共4页
目的探讨血清C1q/肿瘤坏死因子相关蛋白3(CTRP3)、脂蛋白相关磷脂酶A2(Lp-PLA2)、半乳糖凝聚素-3(Gal-3)在原发性高血压继发冠心病患者中的变化及临床意义。方法选取该院2021年2月至2023年2月收治的186例原发性高血压患者为研究对象。... 目的探讨血清C1q/肿瘤坏死因子相关蛋白3(CTRP3)、脂蛋白相关磷脂酶A2(Lp-PLA2)、半乳糖凝聚素-3(Gal-3)在原发性高血压继发冠心病患者中的变化及临床意义。方法选取该院2021年2月至2023年2月收治的186例原发性高血压患者为研究对象。根据患者是否合并冠心病,分为单纯高血压组67例、高血压合并冠心病组119例。比较两组入院时总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C),以及血清CTRP3、Lp-PLA2、Gal-3水平,分析入院时血清CTRP3、Lp-PLA2、Gal-3水平与TC、TG、HDL-C、LDL-C以及继发冠心病的相关性。采用受试者工作特征(ROC)曲线分析血清CTRP3、Lp-PLA2、Gal-3联合检测对原发性高血压继发冠心病风险的预测效能。结果两组TC、TG、HDL-C、LDL-C、CTRP3、Lp-PLA2、Gal-3水平比较,差异均有统计学意义(P<0.05);入院时血清CTRP3水平与TC、TG、LDL-C水平以及继发冠心病均呈负相关(P<0.05),与HDL-C水平呈正相关(P<0.05);入院时血清Lp-PLA2、Gal-3水平与TC、TG、LDL-C水平以及继发冠心病均呈正相关(P<0.05),与HDL-C水平呈负相关(P<0.05);入院时血清CTRP3、Lp-PLA2、Gal-3联合检测预测原发性高血压继发冠心病的曲线下面积为0.924,灵敏度、特异度分别为84.03%、86.57%。结论原发性高血压患者继发冠心病的风险与血清CTRP3、Lp-PLA2、Gal-3水平密切相关,CTRP3、Lp-PLA2、Gal-3可作为原发性高血压患者冠心病早期预防、诊断提供参考依据。 展开更多
关键词 原发性高血压 冠心病 C1q/肿瘤坏死因子相关蛋白3 脂蛋白相关磷脂酶A2 半乳糖凝聚素-3
下载PDF
基于健康生态学的老年冠心病合并高血压患者健康素养现状及影响因素 被引量:1
17
作者 王芬 于培培 +3 位作者 赵文文 刘春梅 李亚芬 王毓 《济宁医学院学报》 2024年第2期111-116,共6页
目的 基于健康生态学视角,分析老年冠心病合并高血压患者健康素养现状及不同层面的影响因素。方法 采用便利抽样法,以2021年12月—2022年5月就诊于山东省某三级甲等医院的住院患者为研究对象,采用一般资料调查表、慢性病患者健康素养量... 目的 基于健康生态学视角,分析老年冠心病合并高血压患者健康素养现状及不同层面的影响因素。方法 采用便利抽样法,以2021年12月—2022年5月就诊于山东省某三级甲等医院的住院患者为研究对象,采用一般资料调查表、慢性病患者健康素养量表、慢性病自我效能量表、社会支持评定量表对175例老年冠心病合并高血压患者进行调查,采用中国公民健康素养调查问卷对其照护者进行调查。结果 老年冠心病合并高血压患者健康素养总分为(95.69±20.86)分。多重线性回归分析结果显示,NYHA心功能分级、慢性病自我效能、社会支持、文化程度是老年冠心病合并高血压患者健康素养的主要影响因素(P<0.05),共解释总变异的43.7%。结论 老年冠心病合并高血压患者健康素养总体水平有待提高。医护人员应重点关注文化程度低、心功能差、社会支持水平低的患者,鼓励患者构建积极的人际关系网络,提高患者自我效能,进而提高患者健康素养水平。 展开更多
关键词 健康生态学 健康素养 冠心病 高血压 自我效能 社会支持
下载PDF
1例高血压合并冠状动脉粥样硬化性心脏病患者药物治疗管理体会
18
作者 赵群 孙喜梅 +1 位作者 司继刚 杨立莉 《中国药业》 CAS 2024年第9期149-152,共4页
目的为高血压合并冠状动脉粥样硬化性心脏病(简称冠心病)患者的药物治疗管理(MTM)提供参考。方法药师通过药学问诊、用药评估、方案调整、用药宣教、药学随访等方式,为1例58岁男性高血压合并冠心病患者提供MTM,并建立MTM档案。结果给予... 目的为高血压合并冠状动脉粥样硬化性心脏病(简称冠心病)患者的药物治疗管理(MTM)提供参考。方法药师通过药学问诊、用药评估、方案调整、用药宣教、药学随访等方式,为1例58岁男性高血压合并冠心病患者提供MTM,并建立MTM档案。结果给予MTM前,患者的血压、心率、低密度脂蛋白胆固醇、甘油三酯、尿酸、同型半胱氨酸水平等动脉粥样硬化性心血管疾病(ASCVD)指标分别为>140/90 mmHg、75~80次/分、2.24 mmol/L、4.34 mmol/L、526µmol/L、17.83µmol/L;经过3个月近20次的MTM后,上述指标均改善,分别降为<130/80 mmHg、55~60次/分、1.62 mmol/L、1.39 mmol/L、342µmol/L、8.55µmol/L。结论该例患者接受MTM后的ASCVD各项指标均达标。医院应开设药学门诊,积极为患者提供MTM,提升药学服务能力和临床合理用药水平。 展开更多
关键词 高血压 冠状动脉粥样硬化性心脏病 药物治疗管理 药学门诊 药学服务
下载PDF
瑞舒伐他汀联合芪参益气滴丸治疗高血压病合并冠状动脉粥样硬化性心脏病疗效及对动脉斑块的影响
19
作者 惠慧 王转转 +2 位作者 廖梅 李光智 吴光鹏 《中华中医药学刊》 CAS 北大核心 2024年第1期222-225,共4页
目的探讨瑞舒伐他汀联合芪参益气滴丸治疗高血压病合并冠状动脉粥样硬化性心脏病的疗效及对动脉斑块的影响。方法选择2021年1月—2021年12月120例高血压病合并冠状动脉粥样硬化性心脏病患者作为研究对象,采用随机数字法平均分为观察组... 目的探讨瑞舒伐他汀联合芪参益气滴丸治疗高血压病合并冠状动脉粥样硬化性心脏病的疗效及对动脉斑块的影响。方法选择2021年1月—2021年12月120例高血压病合并冠状动脉粥样硬化性心脏病患者作为研究对象,采用随机数字法平均分为观察组与对照组,两组患者均给予抗血小板聚集及瑞舒伐他汀稳定斑块等治疗措施,观察组在此基础上联合芪参益气滴丸治疗。比较两组患者临床疗效,心功能、血脂水平、颈动脉斑块及不良反应发生情况。结果观察组总有效率明显高于对照组(P<0.05)。随之治疗时间延长,两组患者左心射血分数(left ventricular ejection fractions,LVEF)及左心室收缩末内径(left ventricular end-diastolic dimension,LVEDD)均逐渐改善(P<0.05);治疗后14 d、3月观察组LVEF及LVEDD均高于对照组(P<0.05)。两组患者治疗后甘油三酯、血清总胆固醇、低密度脂蛋白胆固醇、同型半胱氨酸、C-反应蛋白均逐渐改善(P<0.05);治疗后3个月、6个月观察组甘油三酯、血清总胆固醇、低密度脂蛋白胆固醇、同型半胱氨酸、C-反应蛋白低于对照组(P<0.05)。两组患者治疗后颈动脉内中膜厚度(carotid intima-media thickness,IMT)及不稳定斑块比例逐渐降低(P<0.05);治疗后3个月、6个月观察组IMT急不稳定斑块比例低于对照组(P<0.05)。两组不良反应发生率比较差异无统计学意义(P>0.05)。结论瑞舒伐他汀联合芪参益气滴丸可以更好地促进高血压病伴颈动脉硬化急性心肌梗死患者恢复,更快使血脂异常达标,更有效地抑制颈动脉不稳定斑块形成,且并未增加不良反应。 展开更多
关键词 瑞舒伐他汀 芪参益气滴丸 高血压病 冠状动脉粥样硬化性心脏病 动脉斑块
下载PDF
氨氯地平阿托伐他汀联合循证-情志干预模式对老年高血压合并冠心病患者的应用价值
20
作者 吴祥娜 金莉雅 +2 位作者 梁平平 林朵朵 郑文娴 《中国药师》 CAS 2024年第6期1048-1054,共7页
目的探讨氨氯地平阿托伐他汀钙片(AACT)联合循证-情志干预模式(EENM)对老年高血压合并冠心病(HTN-CHD)患者的应用价值。方法回顾性选取2021年6月至2023年6月温州医科大学附属第二医院心内科收治的HTN-CHD患者为研究对象。根据干预方式不... 目的探讨氨氯地平阿托伐他汀钙片(AACT)联合循证-情志干预模式(EENM)对老年高血压合并冠心病(HTN-CHD)患者的应用价值。方法回顾性选取2021年6月至2023年6月温州医科大学附属第二医院心内科收治的HTN-CHD患者为研究对象。根据干预方式不同,分为AACT组和EENM组。AACT组患者给予AACT联合常规护理干预,EENM组则在AACT组基础上实施EENM。比较两组患者干预前后心理状态[抑郁自评量表(SDS)评分、焦虑自评量表(SAS)和自我感受负担量表(SPBS)]、依从性(遵医服药行为、日常锻炼行为、不良管理行为和饮食管理行为)和血压(收缩压和舒张压)变化情况。观察比较两组患者在6个月心血管事件发生率。结果研究共纳入HTN-CHD患者118例,其中AACT组55例、EENM组63例。干预前,AACT组和EENM组患者SDS评分、SAS评分、SPBS评分、遵医服药行为评分、日常锻炼行为评分、不良管理行为评分、饮食管理行为评分、收缩压和舒张压差异均无统计学意义(P>0.05)。干预后,AACT组和EENM组HTN-CHD患者SDS评分、SAS评分、SPBS评分、收缩压和舒张压较前显著下降(P<0.05),而遵医服药行为评分、日常锻炼行为评分、不良管理行为评分和饮食管理行为评分较前显著上升(P<0.05);EENM组患者SDS评分、SAS评分、SPBS评分、收缩压和舒张压低于AACT组(P<0.05),而遵医服药行为评分、日常锻炼行为评分、不良管理行为评分和饮食管理行为评分高于AACT组(P<0.05)。EENM组心血管事件发生率低于AACT组(P<0.05)。结论EENM联合AACT干预有利于提高HTN-CHD患者依从性,改善心理状态及血压值,降低心血管事件发生率。 展开更多
关键词 氨氯地平阿托伐他汀 循证-情志干预模式 高血压 冠心病 老年人 依从性
下载PDF
上一页 1 2 97 下一页 到第
使用帮助 返回顶部